| AACR Project GENIE: powering precision medicine through an international consortium AACR Project Genie Consortium, AACR Project GENIE Consortium, ... Cancer discovery 7 (8), 818-831, 2017 | 1482 | 2017 |
| Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal I de Bruijn, R Kundra, B Mastrogiacomo, TN Tran, L Sikina, T Mazor, X Li, ... Cancer research 83 (23), 3861-3867, 2023 | 314 | 2023 |
| Association of high tumor mutation burden in non–small cell lung cancers with increased immune infiltration and improved clinical outcomes of PD-L1 blockade across PD-L1 … B Ricciuti, X Wang, JV Alessi, H Rizvi, NR Mahadevan, YY Li, A Polio, ... JAMA oncology 8 (8), 1160-1168, 2022 | 234 | 2022 |
| Genome sequence of an Australian kangaroo, Macropus eugenii, provides insight into the evolution of mammalian reproduction and development MB Renfree, AT Papenfuss, JE Deakin, J Lindsay, T Heider, K Belov, ... Genome biology 12, 1-26, 2011 | 212 | 2011 |
| Serologic response to messenger RNA coronavirus disease 2019 vaccines in inflammatory bowel disease patients receiving biologic therapies SY Wong, R Dixon, VM Pazos, S Gnjatic, JF Colombel, K Cadwell, S Gold, ... Gastroenterology 161 (2), 715-718. e4, 2021 | 111 | 2021 |
| SMARCA4 and other SWItch/sucrose nonfermentable family genomic alterations in NSCLC: clinicopathologic characteristics and outcomes to immune checkpoint inhibition JV Alessi, B Ricciuti, LF Spurr, H Gupta, YY Li, C Glass, M Nishino, ... Journal of Thoracic Oncology 16 (7), 1176-1187, 2021 | 100 | 2021 |
| A randomized trial of combined PD-L1 and CTLA-4 inhibition with targeted low-dose or hypofractionated radiation for patients with metastatic colorectal cancer AM Monjazeb, A Giobbie-Hurder, A Lako, EM Thrash, RC Brennick, ... Clinical Cancer Research 27 (9), 2470-2480, 2021 | 85 | 2021 |
| Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in … JV Alessi, B Ricciuti, SL Alden, AA Bertram, JJ Lin, M Sakhi, M Nishino, ... Journal for Immunotherapy of Cancer 9 (11), 2021 | 80 | 2021 |
| Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer B Ricciuti, JV Alessi, A Elkrief, X Wang, A Cortellini, YY Li, VR Vaz, ... Annals of Oncology 33 (10), 1029-1040, 2022 | 60 | 2022 |
| AACR Project GENIE: 100,000 cases and beyond TJ Pugh, JL Bell, JP Bruce, GJ Doherty, M Galvin, MF Green, ... Cancer Discovery 12 (9), 2044-2057, 2022 | 60 | 2022 |
| Evolution of coding and non-coding genes in HOX clusters of a marsupial H Yu, J Lindsay, ZP Feng, S Frankenberg, Y Hu, D Carone, G Shaw, ... BMC genomics 13, 1-15, 2012 | 54 | 2012 |
| Feature selection and classifier performance on diverse bio-logical datasets E Hemphill, J Lindsay, C Lee, II Măndoiu, CE Nelson BMC bioinformatics 15, 1-14, 2014 | 41 | 2014 |
| Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy S Kaczanowska, T Murty, A Alimadadi, CF Contreras, C Duault, ... Cancer Cell 42 (1), 35-51. e8, 2024 | 34 | 2024 |
| The cBioPortal for cancer genomics and its application in precision oncology J Gao, J Lindsay, S Watt, I Bahceci, P Lukasse, A Abeshouse, HW Chen, ... Cancer Research 76 (14_Supplement), 5277-5277, 2016 | 25 | 2016 |
| MatchMiner: An open source computational platform for real-time matching of cancer patients to precision medicine clinical trials using genomic and clinical criteria J Lindsay, C Del Vecchio Fitz, Z Zwiesler, P Kumari, B Van Der Veen, ... BioRxiv, 199489, 2017 | 21 | 2017 |
| MatchMiner: an open-source platform for cancer precision medicine H Klein, T Mazor, E Siegel, P Trukhanov, A Ovalle, CD Vecchio Fitz, ... npj Precision Oncology 6 (1), 69, 2022 | 20 | 2022 |
| Serological response to mRNA COVID-19 vaccines in IBD patients receiving biological therapies SY Wong, R Dixon, VM Pazos, S Gnjatic, JF Colombel, K Cadwell, S Gold, ... Gastroenterology 161 (2), 715-718, 2021 | 20 | 2021 |
| Impact of aneuploidy and chromosome 9p loss on tumor immune microenvironment and immune checkpoint inhibitor efficacy in NSCLC JV Alessi, X Wang, A Elkrief, B Ricciuti, YY Li, H Gupta, LF Spurr, H Rizvi, ... Journal of Thoracic Oncology 18 (11), 1524-1537, 2023 | 18 | 2023 |
| Network for biomarker immunoprofiling for cancer immunotherapy: cancer immune monitoring and analysis centers and cancer immunologic data commons (CIMAC-CIDC) HX Chen, M Song, HT Maecker, S Gnjatic, D Patton, JJ Lee, SJ Adam, ... Clinical Cancer Research 27 (18), 5038-5048, 2021 | 18 | 2021 |
| Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma S Scalera, B Ricciuti, M Mazzotta, N Calonaci, JV Alessi, L Cipriani, G Bon, ... Annals of Oncology 34 (3), 275-288, 2023 | 17 | 2023 |
Ion MandoiuUniversity of ConnecticutEmail yang diverifikasi di engr.uconn.edu